OssDsign AB

OssDsign AB
About Us
Contacts
Change country

Follow us:
Share:
Subscribe:

About Us

OssDsign is a developer and global provider of next generation bone replacement products. Based on cutting edge material science, the company develops and markets products that support the body's own healing capabilities and thereby improve the clinical outcome in a wide range of orthopedic areas with high medical needs. With a product portfolio consisting of patient-specific implants for cranial surgeries and an off-the-shelf synthetic bone graft for spine surgeries, OssDsign give patients back the life they deserve. The company has a strong commercial presence in the U.S., Europe and selected Asian countries. OssDsign's share is traded on Nasdaq First North Growth Market in Stockholm, Sweden.

Contacts

Morten Henneveld

CEO

+46 18 55 39 93
morten.henneveld@ossdsign.com

OssDsign AB (publ) publishes year-end report 2023

Tue, Feb 06, 2024 07:00 CET

Exceptional sales growth for OssDsign Catalyst confirms the value of our strategy shiftOssDsign AB (publ) announces that the interim report for Q4 2023 is now available as a PDF on the company’s website www.ossdsign.com/reports. A PDF version is also attached to this press release. The Q4 2023 results will also be presented at an investor webcast today February 6th at 10:00 CET. The webcast can be accessed via the following link: https://www.finwire.tv/webcast/ossdsign/ossdsign-year-end-report-2023/

There are no items matching the current filter

There are no more items matching the current filter

About Us

Contacts

Links

OssDsign AB (publ) publishes year-end report 2023

Subscribe

Media

Share

About Us

Contacts

Links

OssDsign AB (publ) publishes year-end report 2023

Subscribe

Media